Indirect Clinical Validation of a Programmed Death-Ligand 1 Laboratory-Developed Test for Gastric/Gastroesophageal Junction Adenocarcinoma with 22C3 Antibody Concentrate.
Mol Diagn Ther
; 26(6): 679-688, 2022 11.
Article
in En
| MEDLINE
| ID: mdl-36125657
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adenocarcinoma
/
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Guideline
Limits:
Humans
Language:
En
Journal:
Mol Diagn Ther
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACOLOGIA
/
TECNICAS E PROCEDIMENTOS DE LABORATORIO
Year:
2022
Document type:
Article
Affiliation country:
South Korea
Country of publication:
New Zealand